Archived articles

Immunotherapy

Research matters

Biological targets could halt breast cancer metastasis

Published April 9, 2025

Thanks to the NIH, researchers like Andrew Ewald have advanced our understanding of what allows a cancer cell from one part of the body to successfully grow in another part

Research in action

A miracle in her own backyard

Published March 10, 2025

NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center

Student Scholar

Biomedical engineering doctoral student named Quad Fellow

Published Aug 16, 2024

Benjamin Biggs among recipients of highly competitive award for exceptional master's and doctoral students to study STEM in the U.S.

Immunotherapy

Toxic trade-offs

Published March 17, 2023

While advances in immunotherapy have dramatically improved cancer survival, unleashing the immune system can lead to a host of adverse reactions. How can patients pay less of a price?

Cancer research

Machine learning can help predict patient response to cancer immunotherapy

Published Nov 17, 2022

Algorithm gives insights into the biology behind an effective immune response

Cancer research

FDA approves new immunotherapy treatment regimen for melanoma patients

Published March 25, 2022

The treatment was developed and studied by researchers at Johns Hopkins and targets aggressive forms of skin cancer

Elizabeth Jaffee and First Lady Jill Biden, both wearing masks, pose for a photo together at the the White House

Q+A

Cancer Moonshot renewal could bring ambitious goals within reach

Published Feb 8, 2022

Johns Hopkins cancer researcher Elizabeth Jaffee, who co-led the Cancer Moonshot Blue Ribbon Panel in 2016, discusses how far cancer research has come in the past five years and where it's headed in the next few decades